Related Experiment Video
Updated: May 29, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Stress-related cardiomyopathies.
1AP-HP, Hôpital de Bicêtre, service de réanimation médicale, Le Kremlin-Bicêtre, F-94270 France. christian.richard@bct.aphp.fr.
Stress-related cardiomyopathies, including Takotsubo cardiomyopathy, involve acute left ventricular dysfunction triggered by catecholamines. Understanding the heart-brain interaction is crucial for developing therapeutic strategies.
Area of Science:
- Cardiology
- Neuroscience
- Endocrinology
Background:
- Stress-related cardiomyopathies encompass Takotsubo cardiomyopathy, neurogenic stress-related cardiomyopathy (following subarachnoid hemorrhage or stroke), and myocardial dysfunction in pheochromocytoma, critical illness, or exogenous catecholamine administration.
- Cardiac toxicity appears primarily mediated by direct neural catecholamine release into the heart, rather than systemic circulation.
- The intricate mechanisms linking life-threatening stress, autonomic storm, and myocardial toxicity are under extensive investigation.
Purpose of the Study:
- To review the clinical contexts, diagnostic criteria, and proposed mechanisms of stress-related cardiomyopathies.
- To highlight the role of catecholamines, both endogenous and exogenous, in mediating cardiac dysfunction.
- To emphasize the need for further research into the heart-brain axis and preventative strategies.
Main Methods:
- Review of existing literature on stress-related cardiomyopathies.
- Discussion of diagnostic criteria, including the four Mayo Clinic criteria for Takotsubo cardiomyopathy.
- Analysis of proposed pathophysiological mechanisms involving catecholamine release and autonomic dysregulation.
Main Results:
- Takotsubo cardiomyopathy is a recognized, reversible condition characterized by specific left ventricular wall motion abnormalities and ECG changes.
- Neurocardiogenic stunning, or neurogenic stress-related cardiomyopathy, frequently occurs after subarachnoid hemorrhage and ischemic stroke.
- Elevated catecholamine levels are implicated in myocardial dysfunction across various critical conditions.
Conclusions:
- Stress-induced cardiomyopathies manifest in diverse clinical scenarios, often linked to catecholamine excess.
- The direct neural pathway of catecholamine release plays a significant role in cardiac toxicity.
- Further research is essential to elucidate the heart-brain interaction, identify risk factors, and develop effective treatments.
More Related Videos
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Myocarditis I: Introduction